[
  {
    "text": "License and Development Agreement.",
    "bbox": [
      937,
      73,
      1000,
      84
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Licensed",
    "bbox": [
      179,
      107,
      250,
      118
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Any and all products that are manufactured, sold, or otherwise supplied by the Licensee (including any Affiliate or",
    "bbox": [
      293,
      107,
      1000,
      119
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Product",
    "bbox": [
      178,
      122,
      243,
      135
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Distributor of the Licensee) and which incorporate, or their development makes use of, any Intellectual Property or",
    "bbox": [
      291,
      122,
      1000,
      135
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Developed Intellectual Property.",
    "bbox": [
      291,
      138,
      534,
      152
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Licensee",
    "bbox": [
      177,
      154,
      250,
      167
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "shall mean with respect to the Licensed Product (as defined hereunder) all know-how, trade secrets and scientific, technical,",
    "bbox": [
      291,
      154,
      1000,
      167
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Know-how",
    "bbox": [
      179,
      171,
      257,
      182
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "including manufacturing or regulatory information, developed, applied or acquired by Eurofarma which relates to the",
    "bbox": [
      293,
      171,
      1000,
      183
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "identification, characterization, expression, synthesis, use, or production of the Licensed Product and which is reasonably",
    "bbox": [
      292,
      187,
      1000,
      199
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "useful or necessary to research, develop, use, make, have made, import, distribute, offer for sale, and/or sell the Licensed",
    "bbox": [
      292,
      203,
      1000,
      215
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Product.",
    "bbox": [
      291,
      218,
      356,
      231
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Losses",
    "bbox": [
      176,
      233,
      235,
      247
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "shall have the meaning set forth in Article 17.1 of this Agreement.",
    "bbox": [
      291,
      234,
      784,
      247
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Marketing",
    "bbox": [
      178,
      249,
      264,
      264
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "in relation to the Licensed Product, shall mean those approvals necessary from one or more competent authorities in the",
    "bbox": [
      292,
      251,
      1000,
      263
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Authorisation Territory for manufacturing, importing, marketing, distributing, offering for sale and/or selling the Licensed Product in one",
    "bbox": [
      179,
      266,
      1000,
      279
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "/MA",
    "bbox": [
      177,
      282,
      220,
      295
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "or several countries of the Territory..",
    "bbox": [
      291,
      282,
      561,
      295
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Net Sales",
    "bbox": [
      177,
      297,
      254,
      311
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "means the total of the gross invoice prices of Licensed Products sold or leased by the Licensee, an Affiliate, a Distributor,",
    "bbox": [
      291,
      298,
      1000,
      312
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "or any combination thereof, less the sum of the following actual and customary deductions where applicable and separately",
    "bbox": [
      291,
      315,
      1000,
      327
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "listed: cash, trade, or quantity discounts; sales, use, tariff, import/export duties or other excise taxes imposed on particular",
    "bbox": [
      291,
      330,
      1000,
      343
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "sales (in particular value-added tax); transportation charges; or credits to customers because of rejections or returns. For",
    "bbox": [
      293,
      347,
      1000,
      359
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "purposes of calculating Net Sales, transfers to an Affiliate or to a Distributor of Licensed Product under this Agreement for",
    "bbox": [
      292,
      362,
      1000,
      375
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "(i) end use (but not resale) by the Affiliate shall be treated as sales by Licensee at the list price of the Licensee in an arm-",
    "bbox": [
      293,
      378,
      1000,
      391
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "length transaction, or (ii) resale by an Affiliate shall be treated as sales at the list price of the Affiliate.",
    "bbox": [
      293,
      395,
      1000,
      407
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Patents",
    "bbox": [
      179,
      410,
      239,
      422
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "shall mean Brazilian Patent Application No. BR 11 2018 068143 filed on September 6, 2018, and Mexican Patent Application",
    "bbox": [
      293,
      411,
      1000,
      423
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "No. MX/a/2018/010864 filed on September 7, 2018, covering multi-layered formulation of Mazindol, including all provisional",
    "bbox": [
      291,
      426,
      1000,
      439
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "applications, continuations, divisions, extensions, re-examinations, certificates, reissues and Supplementary Protection",
    "bbox": [
      293,
      443,
      1000,
      455
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Certificates.",
    "bbox": [
      293,
      458,
      382,
      470
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Phase III",
    "bbox": [
      180,
      475,
      247,
      485
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "shall mean a controlled clinical study of mazindol CR that aims to establish the therapeutic benefit and safety of mazindol",
    "bbox": [
      291,
      474,
      1000,
      487
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Clinical Trial CR in the Field in a larger patient sample in a manner sufficient to be included in the Dossier and obtain one or several",
    "bbox": [
      178,
      489,
      1000,
      504
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Marketing Authorisations to market such Licensed Product in the Territory.",
    "bbox": [
      291,
      506,
      856,
      519
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "3",
    "bbox": [
      660,
      538,
      672,
      550
    ],
    "label": 33,
    "category": "Audit Rights"
  },
  {
    "text": "Source: NLS PHARMACEUTICS LTD., F-1, 2/28/2020",
    "bbox": [
      133,
      1000,
      547,
      1000
    ],
    "label": 33,
    "category": "Audit Rights"
  }
]